by Adam | Mar 27, 2020 | News
March 26, 2020 04:42 PM Eastern Daylight Time NEW YORK–(BUSINESS WIRE)–EpiVax Oncology, Inc., a precision cancer immunotherapy company, today announced it has reduced the timeline from biopsy to vaccine to under 4 weeks for its personalized neoantigen...
by Annie De Groot | Jun 28, 2019 | Events
7th Annual Cambridge Healthtech Institute’s Immuno-Oncology Summit Powering Next Generation Targeted Immunotherapies Monday, August 5th – Friday August 9th Westin Boston Waterfront 425 Summer Street Boston, MA 02210 UPDATE: EpiVax Oncology (EO) would like...
by Annie De Groot | Mar 29, 2019 | Events
CIMT 2019 Annual Meeting Tuesday, May 21st – Thursday, May 23rd Rheingoldhalle Congress Center Mainz, Germany Meet members of EpiVax Oncology at the 2019 CIMT meeting, scheduled from May 21-23 at the Rheingoldhalle Congress Center in Mainz, Germany. Every year,...
by Annie De Groot | Mar 28, 2019 | Events
Frontiers in Cancer Immunotherapy Symposium Tuesday, May 14th – Wednesday, May 15th Registration starts at 8:30A.M. on Tuesday The New York Academy of Sciences 7 World Trade Center New York City, New York Meet EpiVax Oncology’s CEO/Co-Founder, Gad Berdugo,...
by Adam | Mar 28, 2019 | News
THIS ORIGINAL ARTICLE WAS PUBLISHED IN PR NEWSWIRE. LINK TO THE ORIGINAL ARTICLE CAN BE FOUND HERE. NEW YORK, March 25, 2019 /PRNewswire/ — EpiVax Oncology, Inc., a precision cancer immunotherapy company, today announced that its abstract has been selected for...